Ind-Swift Laboratories Limited — Others, 14-02-2025: Monitoring Agency Report

Ind-Swift Laboratories Limited has submitted a Monitoring Agency Report, confirming that the Rs. 314.60 crore raised through a preferential issue for fully convertible warrants is being utilized as disclosed in the offer document. No deviations were noted in fund usage, with funds allocated for various objectives, including debt repayment and corporate purposes. The report also reflects a strategic shift, as the company has sold its API manufacturing business but plans to merge with a group entity engaged in formulations, indicating potential for future growth. This strategic maneuver may enhance investor sentiment, providing a positive outlook as the company pivots toward high-value formulations.